**Retail Earnings in Focus: How Tariffs and Inventory Accounting May Impact Profits**
As the retail giants Home Depot, Target, and Walmart prepare to…
How retail accounting could distort profitability as tariffs take effect
Blog
Powell Has Reason to Hedge Jackson Hole Signal as Data Zigzags
**Fed Watch: What to Expect from Jackson Hole and the Broader market Implications**
As the Federal Reserve’s annual Jackson Hole symposium approaches…
What Are Private Equity’s Continuation Funds? How Do They Work?
**Private Equity in Peril: How Rising Interest Rates Are Impacting the Industry**
**The Boom Years: Low Interest Rates Fuel Private Equity Growth**
…
As Bitcoin strengthens, Strategy faces a test of relevance
**The Great Disconnect: Why Bitcoin Soars While Strategy Shares Stumble**
**Bitcoin’s Record-Breaking Rally Leaves Strategy in the Dust**
In a surpr…
U.S. Treasury Department Starts Work on GENIUS, Gathering Views on Illicit Activity
**Stablecoin Regulation Heats Up: What the Treasury’s New Move Means for Crypto Investors**
**The Crypto Regulatory Landscape Shifts**
In a signific…
Stellar Development Foundation Invests in Archax, Aiming to Boost Tokenization
**Stellar Integration: A New Era for Tokenized Investments?**
**Unlocking the Power of blockchain in Traditional Finance**
In a significant move, a …
Sherrod Brown, targeted by crypto PAC in 2024, to run for US Senate again
**Crypto’s Growing Influence: A Look at the Most Expensive Senate Race in Ohio’s History**
**The Rise of Crypto-Backed Political Campaigns**
The 202…
Sebi mulls relaxing minimum public offer size for large cos; to trim retail quota in IPO
**Sebi Proposes Relaxation of Minimum Public Offer Requirements: What It Means for Investors**
**Boosting Liquidity and Accessibility in Indian marke…
Market Trading Guide: Blue Star and a midcap stock are buy recommendations for Tuesday. Up to 6% upside seen
**Indian markets Soar on GST Reform Hopes: What’s Driving the Rally?**
**GST Reform Expectations Boost Indian Markets**
Indian markets witnessed a s…
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
**Novo Nordisk’s Ozempic Pricing Strategy: A Game-Changer for Investors?**
**market Context: A Shift in Healthcare Affordability**
The healthcare in…